Jun . 05, 2026 10:31 Back to list
In modern infectious disease diagnostics, the demand for rapid, portable, and highly accurate testing solutions continues to grow. Enteroviruses such as EV71 and CoxA16 remain major pathogens responsible for hand, foot, and mouth disease (HFMD), particularly in pediatric populations. Early and reliable detection is essential for timely treatment, infection control, and public health surveillance.
Cowin Gene is committed to advancing molecular POCT (Point-of-Care Testing) technology, providing clinicians and patients with fast, easy-to-operate, and highly sensitive diagnostic solutions. Its core product portfolio is based on PCR technology, enabling the rapid detection of multiple pathogens, including viruses, bacteria, and fungi, within a simplified workflow.
With a strong team of senior scientists, engineers, and marketing experts, Cowin Gene continuously focuses on innovation and product optimization. Its R&D center is equipped with advanced laboratory instruments and operates under a strict quality management system to ensure that every product meets international in vitro diagnostic standards. The company aims to become a global leader in molecular POCT, delivering fast and reliable diagnostic solutions to improve healthcare outcomes worldwide.

The Cowingene NATBox detection kit is an integrated molecular diagnostic solution designed for the qualitative detection of Enterovirus Universal (EVU), EV71, and CoxA16 RNA in a single PCR analysis. By combining target amplification and simplified operation within a compact system, it significantly improves testing efficiency and reduces laboratory complexity.
This kit is specifically designed for use with the NATBox® Mini II system, enabling fully integrated molecular testing at the point of care. It is ideal for hospitals, clinics, and emergency testing environments where rapid results are critical for patient management.
With a limit of detection (LoD) of 400 copies/mL for all targets, the kit provides high sensitivity and reliable performance even in low viral load samples. Its compact format and streamlined workflow make it a practical solution for decentralized testing scenarios.
This integrated NATBox PCR kit is designed to perform simultaneous detection of EV71, CoxA16, and Enterovirus Universal in a single closed system. It eliminates the need for complex laboratory procedures, reducing the risk of contamination and improving operational safety.
The kit supports clinical specimens such as human stool and vomitus, making it suitable for gastrointestinal and systemic enterovirus infection detection. Its closed-cartridge system ensures minimal handling steps, allowing healthcare professionals to perform testing with ease and confidence.
Cowin Gene’s advanced molecular design ensures high specificity and reproducibility, enabling accurate differentiation between viral targets within a single test run.
This portable NATBox molecular diagnostic kit is designed to bring high-quality PCR testing closer to the patient. Its compact design and integration with the NATBox® Mini II system make it ideal for point-of-care environments, including emergency departments, outpatient clinics, and remote healthcare facilities.
The system allows for simplified sample processing, where reagents such as lysis buffer and controls are directly integrated into the cartridge system. Once the cartridge is prepared, it should be used within 30 minutes to ensure optimal performance and accuracy.
Storage conditions of 2–8°C for up to 12 months ensure excellent reagent stability, while transport at the same temperature for up to 15 days supports flexible logistics and distribution.
The NATBox system provides a high-efficiency solution for molecular diagnostics, combining automated processing with real-time PCR detection. It is specifically engineered to improve workflow efficiency and reduce manual intervention in clinical testing environments.
Each test cartridge is designed for single-use operation, ensuring contamination-free results and consistent diagnostic accuracy. The system’s compatibility with standardized NATBox instrumentation ensures seamless integration into existing diagnostic workflows.
Recommended supporting reagents, including sample diluent and NATBox system hardware, further enhance performance and ensure a complete and optimized testing solution.
Cowin Gene’s molecular POCT products deliver significant advantages in clinical diagnostics, including rapid detection time, simplified operation procedures, and high sensitivity performance. These features make them highly suitable for hospitals, laboratories, and point-of-care testing environments.
The company’s core product line is based on advanced PCR technology, enabling the detection of a wide range of pathogens, including viruses, bacteria, and fungi. Each product is developed under a strict quality management system to ensure compliance with international in vitro diagnostic standards.
The Cowingene Enterovirus Universal, EV71 and CoxA16 NATBox Detection Kit is designed for streamlined molecular testing, providing a fully integrated solution from sample processing to result interpretation. Its closed-system design reduces contamination risk and improves diagnostic safety.
Cowin Gene continues to invest heavily in research and development, driving innovation in molecular POCT technology. With a vision to become a global leader in in vitro diagnostics, the company is committed to delivering fast, reliable, and accessible diagnostic solutions that contribute to improved global healthcare and disease control.
Related PRODUCTS
Meet COWIN GENE at WHX Bangkok 2026!
NewsJun.09,2026Supporting Ebolavirus Surveillance with Real-time PCR Detection
NewsMay.27,20267 Days To Go Until Whx Lagos 2026!
NewsMay.26,2026Compact Molecular Testing for Accurate Malaria Detection
NewsJul.20,2026Comprehensive HPV Genotyping. Reliable Molecular Diagnostics
NewsJul.17,2026Rapid Molecular Detection of EV71 & CoxA16 with High Stability Lyophilized PCR Kit
NewsJul.16,2026